Will topical NSAIDs help with chronic musculoskeletal pain?
Vanessa Jordan
+ Author Affiliations
- Author Affiliations
Correspondence to: Vanessa Jordan, New Zealand Cochrane Fellow, University of Auckland, Auckland, New Zealand. Email: Vanessa Jordan v.jordan@auckland.ac.nz
Journal of Primary Health Care 8(2) 179-179 https://doi.org/10.1071/HC15904
Published: 30 June 2016
Journal Compilation © Royal New Zealand College of General Practitioners 2016.
This is an open access article licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
[1] NICE clinical guidelines, Osteoarthritis. Care and management in adults. 2014. 177.[2] Conaghan PG, , et al. Drug-free gel containing ultra-deformable phospholipid vesicles (TDT 064) as topical therapy for the treatment of pain associated with osteoarthritis: a review of clinical efficacy and safety. Curr Med Res Opin 2014; 30 599–611.
| Drug-free gel containing ultra-deformable phospholipid vesicles (TDT 064) as topical therapy for the treatment of pain associated with osteoarthritis: a review of clinical efficacy and safety.Crossref | GoogleScholarGoogle Scholar |
[3] Derry S, et al. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database of Systematic Reviews, 2016(4).
